Zydus Loses Patent Battle Over Bladder Drug Myrbetriq In US, Jury Trial Set for 2026 Farhat Nasim17 April 2025 6:55 PM ISTNew Delhi: Indian drugmaker Zydus Lifesciences has received a legal setback in the United States after the District Court of Delaware ruled in favour...
Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron Dr. Divya Colin14 March 2025 4:00 PM ISTNew Delhi: Responding to the revised Phase III clinical trial protocol of fixed dose combination (FDC) Tamsulosin plus MirabegronIP 0.4 mg/0.4 mg +...
Revise Phase III CT Protocol:Â CDSCO Panel Tells Windlass Biotech on FDC Tamsulosin Hydrochloride plus Mirabegron Dr. Divya Colin15 Aug 2024 5:00 PM ISTNew Delhi: In response to the proposal presented by the drug maker Windlass Biotech, the Subject Expert Committee (SEC) functional under the Central...
Justify bioequivalent data: CDSCO Panel Tells Sun Pharma on Mirabegron Extended-release Tablets Dr. Divya Colin8 March 2024 6:00 PM ISTNew Delhi: After reviewing the bioequivalence (BE) report of Mirabegron extended-release Tablets 50 mg presented by drug major Sun Pharma, the Subject...
CDSCO Panel Rejects MSN Laboratories Proposal For Combikit of Silodosin Capsules plus Mirabegron Dr. Divya Colin15 Oct 2023 6:30 PM ISTNew Delhi: Highlighting that there is no unmet need for the proposed Combi kit of Silodosin Capsules 8mg/8mg plus Mirabegron extended released (ER)...
Urinary urobiome modification tied to improvement of urgency urinary incontinence symptoms after taking mirabegron Jacinthlyn Sylvia6 July 2023 8:00 PM ISTA recent study by Thomas Halverson and team suggested that longitudinal urobiome modifications are linked to symptom relief in adult women taking...
MSN Laboratories gets CDSCO panel nod for FDCs Solifenacin, Mirabegron capsules Dr. Divya Colin30 March 2022 7:21 PM ISTNew Delhi: In a significant development, MSN Laboratories has got approval from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Mirabegron a valuable drug for management of irritative symptoms after TURBT: Study Dr. Shravani Dali4 Oct 2021 9:00 AM ISTMirabegron effective for the management of irritative symptoms after transurethral resection of bladder tumours (TURBT), suggests a study published ...
Mirabegron beneficial in children with neurogenic detrusor overactivity: Study Dr. Shravani Dali25 Aug 2021 9:00 AM ISTMirabegron is significantly useful in children above three years with lower urinary tract dysfunction, suggests a study published in the...
FDA Approves mirabegron for Neurogenic Detrusor Overactivity in kids Dr. Kamal Kant Kohli26 March 2021 10:00 AM ISTOveractive bladder is a bladder dysfunction related to neurological impairment.The U.S. Food and Drug Administration has approved a new indication for...
Mirabegron may be treatment of choice in OAB after failure of antimuscarinic therapy MD Bureau17 Feb 2021 10:45 AM ISTOveractive bladder is highly prevalent in men. Lower urinary tract symptoms (LUTS) and overactive bladder with (OAB-wet) or without (OAB-dry) urgency...
